Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles.
about
Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@en
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@nl
type
label
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@en
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@nl
prefLabel
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@en
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@nl
P2093
P2860
P356
P1433
P1476
Targeted therapy of triple neg ...... ed phospholipid nanoparticles.
@en
P2093
Da Hae Kim
Jin Hee Lee
Jin Won Park
Kyung-Han Lee
Kyung-Ho Jung
Seung-Hwan Moon
Young Seok Cho
P2860
P304
P356
10.3892/OL.2018.8471
P577
2018-04-12T00:00:00Z